Sun.Mar 30, 2025

article thumbnail

Q&A: How Independent Pharmacists Navigated the COVID-19 Pandemic

Drug Topics

Tom DePietro, PharmD, owner of DePietro's Pharmacy, highlights the deep community connections that enabled the pharmacy to respond effectively to the pandemic.

247
247
article thumbnail

Are Fake Online Pharmacies Ripping You Off?

The Happy PharmD

If you think your patients arent looking at online pharmacies for cheaper medications, youre kidding yourself. Medicine is expensiveeverything is expensive. And when people are desperate, they look for alternatives. The problem? 96% of online pharmacies are illegal. Theyre selling unregulated, potentially dangerous medications, and most patients have no idea.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ACC 2025: Oral Semaglutide Reduces Cardiovascular Events by 14% at 4 Years

Pharmacy Times

The trial is the first to test the cardiovascular benefits of an oral glucagon-like peptide-1 (GLP-1) agonist.

143
143
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

The federal government has turned its focus to monitoring the billing practices of remote physiologic monitoring and remote therapeutic monitoring over the last two years. Health systems have followed suit.

63
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

ACC 2025: Intravenous Iron Safe, but Results in Mixed Findings for Patients With Heart Failure

Pharmacy Times

Patients in the treatment group had a 21% lower risk of cardiovascular death or first heart failure hospitalization overall, but the between-group difference did not meet the threshold for statistical significance for this primary end point.

Hospitals 117
article thumbnail

STAT+: FDA’s ‘key man’ Peter Marks is out. Biotech investors will now deal with the consequences

STAT

Robert F. Kennedy Jr. forcing Peter Marks out of the Food and Drug Administration has blown a hole in the agency’s leadership ranks and threatens to unmoor the oversight of drugs and vaccines from bedrock scientific principles.  For biotech investors, Marks’ ouster is a worst-case scenario realized — an FDA riven by dysfunction and uncertainty.

FDA 142

More Trending

article thumbnail

It’s a Bird, It’s a Plane, It’s Operation Stork Speed

The FDA Law Blog

By Charles D. Snow & Deborah L. Livornese & Ricardo Carvajal On March 18, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) launched a significant initiative called Operation Stork Speed to bolster the availability and safety of infant formula in the United States ( link , link ). This initiative seeks to address the ongoing challenges families face in ensuring they have access to safe, reliable, and nutritious infant formula and is

FDA 59
article thumbnail

FINEARTS-HF Analysis: How Liver Biomarkers Influence Heart Failure Risk

Pharmacy Times

Jawad Butt, MD, offers insight into his analysis of the FINEARTS-HF trial.

65
article thumbnail

Risperidone Causing Tardive Dyskinesia – Case Sceniaro

Med Ed 101

In this case scenario, we outline a situation of risperidone causing tardive dyskinesia. Tardive dyskinesia is a neurological movement disorder that is typically caused by medications that can block dopamine receptors. Antipsychotics are the most commonly used class of medication that block dopamine receptors (great board exam question). ME is a 55-year-old male who has […] The post Risperidone Causing Tardive Dyskinesia – Case Sceniaro appeared first on Med Ed 101.

52